Clinical Trial Update: Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial of liposomal doxorubicin in combination with estramustine phosphate for taxane-resistant, hormone-refractory advanced prostate cancer was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Estramustine phosphate (estramustine phosphate)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Morton Plant Mease Health Care | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED